We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.78B
AUM Growth
Cap. Flow
+$4.65B
Cap. Flow %
97.21%
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$91.9M
2
CELG
Celgene Corp
CELG
+$79.7M
3
AAPL icon
Apple
AAPL
+$78.2M
4
QCOM icon
Qualcomm
QCOM
+$73.5M
5
AMGN icon
Amgen
AMGN
+$71.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 24.38%
2 Financials 14.02%
3 Technology 12.7%
4 Industrials 8.01%
5 Energy 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECK icon
601
Teck Resources
TECK
$29.5B
$208K ﹤0.01%
+15,203
New +$232K
WYNN icon
602
Wynn Resorts
WYNN
$10.1B
$208K ﹤0.01%
+1,396
New +$240K
HP icon
603
Helmerich & Payne
HP
$3.53B
$206K ﹤0.01%
+3,057
New +$238K
WPM icon
604
Wheaton Precious Metals
WPM
$50.6B
$202K ﹤0.01%
+9,923
New +$197K
NVCN
605
DELISTED
Neovasc Inc.
NVCN
$199K ﹤0.01%
+1
New +$151K
PBR icon
606
Petrobras
PBR
$121B
$111K ﹤0.01%
+15,220
New +$164K
CIE
607
DELISTED
Cobalt International Energy, Inc
CIE
$99K ﹤0.01%
+746
New +$114K

Similar funds

Candriam SCA's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Candriam SCA, which disclosed 616 positions worth $4.78B. Its ten largest holdings account for 14% of the portfolio.

Its largest position is Gilead Sciences: 888,125 shares worth $83.7M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Technology.

  • Candriam SCA's largest Q4 2014 buy was Gilead Sciences: 888,125 shares worth $83.7M.
  • Candriam SCA's ten largest holdings make up 14% of its $4.78B portfolio in Q4 2014.
  • Candriam SCA disclosed 616 positions in Q4 2014, its first 13F filing on record.

Based on Candriam SCA's 13F filing for Q4 2014, filed 26 Mar 2015.